Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)

被引：0

作者：

Hiroshi Nomoto

Chiho Oba-Yamamoto

Yuka Takahashi

Jun Takeuchi

So Nagai

Hiroki Yokoyama

Shinji Taneda

Yoshio Kurihara

Shin Aoki

Hiraku Kameda

Kyu Yong Cho

Akinobu Nakamura

Tatsuya Atsumi

Hideaki Miyoshi

机构：

[1] Hokkaido University,Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine

[2] Sapporo Diabetes and Thyroid Clinic,Division of Diabetes and Endocrinology, Department of Medicine, Sapporo Medical Center

[3] NTT East Corporation,Department of Internal Medicine

[4] Jiyugaoka Medical Clinic,Diabetes Center

[5] Manda Memorial Hospital,Clinical Research and Medical Innovation Center

[6] Kurihara Clinic,Division of Diabetes and Obesity, Faculty of Medicine and Graduate School of Medicine

[7] Aoki Clinic,undefined

[8] Hokkaido University Hospital,undefined

[9] Hokkaido University,undefined

来源：

Diabetes Therapy | 2021年 / 12卷

关键词：

Glucagon-like peptide-1 receptor agonist; Treatment satisfaction; Type 2 diabetes mellitus;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

页码：955 / 964

页数：9

共 31 条